These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 1969993)
21. Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML. Madhusudana SN; Sanjay TV; Mahendra BJ; Sudarshan MK; Narayana DH; Giri A; Muhamuda K; Ravi V; Vakil HB; Malerczyk C Hum Vaccin; 2006; 2(5):200-4. PubMed ID: 17035734 [TBL] [Abstract][Full Text] [Related]
23. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Quiambao BP; Dimaano EM; Ambas C; Davis R; Banzhoff A; Malerczyk C Vaccine; 2005 Feb; 23(14):1709-14. PubMed ID: 15705476 [TBL] [Abstract][Full Text] [Related]
24. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study. Cantaert T; Borand L; Kergoat L; Leng C; Ung S; In S; Peng Y; Phoeun C; Hing C; Taing CN; Saman M; Ong S; Mey C; Choeung R; Ly S; Dussart P; Bourhy H; Tarantola A Lancet Infect Dis; 2019 Dec; 19(12):1355-1362. PubMed ID: 31570311 [TBL] [Abstract][Full Text] [Related]
25. Rabies intradermal post-exposure vaccination of humans using reconstituted and stored vaccine. Kamoltham T; Khawplod P; Wilde H Vaccine; 2002 Sep; 20(27-28):3272-6. PubMed ID: 12213396 [TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis. Tantawichien T; Sibunruang S; Tantawichien T; Angsanakul J; Benjavongkulchai M; Limsuwan K; Udomchaisakul P; Khomvilai S; Sitprija V Expert Rev Vaccines; 2014 Dec; 13(12):1593-601. PubMed ID: 25315021 [TBL] [Abstract][Full Text] [Related]
32. Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine. Beran J; Honegr K; Banzhoff A; Malerczyk C Vaccine; 2005 Jun; 23(30):3902-7. PubMed ID: 15917111 [TBL] [Abstract][Full Text] [Related]
33. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis. Tantawichien T; Tantawichien T; Supit C; Khawplod P; Sitprija V Clin Infect Dis; 2001 Dec; 33(12):2085-7. PubMed ID: 11712097 [TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India. Matha IS; Salunke SR Clin Infect Dis; 2005 Feb; 40(4):611-3. PubMed ID: 15712086 [TBL] [Abstract][Full Text] [Related]